Breaking News Instant updates and real-time market news.

DRNA

Dicerna

$10.76

-0.395 (-3.54%)

07:08
01/22/19
01/22
07:08
01/22/19
07:08

Dicerna upgraded to Buy from Neutral at Chardan

DRNA Dicerna
$10.76

-0.395 (-3.54%)

11/27/18
LEER
11/27/18
INITIATION
LEER
Leerink initiates select Genetic Medicine names on increasing regulatory clarity
Leerink analyst Mani Foroohar initiated select Genetic Medicine stocks, stating that the field is "is rich with companies developing drugs" to treat rare diseases and that he is increasingly more bullish on "innovation velocity and increasing regulatory clarity in the sector. Based on his "balanced view of pricing dynamics", the analyst issues an Outperform rating on Wave Life Sciences (WVE), Rocket Pharmaceuticals (RCKT), Intellia Therapeutics (NTLA), Eidos Therapeutics (EIDX), Dicerna (DRNA) and Bluebird Bio (BLUE). The analyst likes Wave Life Sciences as a pure play on Oligotherapeutics and its stereopure chemistry platform as a differentiated approach to oligo drug design. Foroohar is positive on Rocket Pharma's lead assets in gene therapies for Fanconi Anemia and Leukocyte Adhesion Deficiency-I "which will likely be the company's first potential approved product." The analyst is positive on Intellia Therapeutics' "robust balance sheet to support development, trading at a material discount to closest comps peers". For Eidos, the analyst cites the prospects of its drug candidate for TTR amyloidosis currently in a placebo-controlled Phase 2 study that may offer a competitive profile relative to Pfizer's (PFE) tafamidis. For Dicerna, Foroohar notes that its DCR-PHXC "is an RNAi therapeutic that targets lactate dehydrogenase A for the treatment of all subtypes of Primary Hyperoxaluria vs. competitor Alnylam's (ALNY) lumasiran, which only treats PH Type 1. For Bluebird Bio, the analyst is positive on its position as a "leader in ex vivo gene therapy, with four programs with visibility towards near-term regulatory approval". Foroohar initiates Avrobio (AVRO), Alnylam (ALNY), and Ionis Pharmaceuticals (IONS) with Market Perform rating based on competitive launches for their products along with "mixed" early signs of their results. The analyst also rates Regenxbio (RGNX) at underperform, saying that its "current valuation more than accounts for robust royalty streams from sales in spinal muscular atrophy" and other partnered assets.
11/27/18
LEER
11/27/18
INITIATION
Target $24
LEER
Outperform
Dicerna initiated with an Outperform at Leerink
Leerink analyst Mani Foroohar initiated Dicerna with an Outperform rating and a price target of $24.
11/06/18
RILY
11/06/18
UPGRADE
Target $21
RILY
Buy
Dicerna upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Madhu Kumar upgraded Dicerna Pharmaceuticals to Buy and raised his price target for the shares to $21 from $13.50 following last night's Q3 results. The analyst says Dicerna's "strong" balance sheet supports its "broad" RNAi platform.
10/31/18
HCWC
10/31/18
NO CHANGE
Target $24
HCWC
Buy
Dicerna price target raised to $24 after Lilly, Alexion pacts at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target on Dicerna (DRNA) shares to $24 from $20 after the company announced collaborations with Eli Lilly (LLY) and Alexion Pharmaceuticals (ALXN). Arce views these partnerships as further strong validation of Dicerna's GalXC RNAi platform and keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Earnings
Steelcase reports Q4 EPS 29c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

MYL

Mylan

$28.61

0.44 (1.56%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Initiation
Mylan initiated  »

Mylan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALTR

Altair

$37.68

-0.51 (-1.34%)

16:43
03/19/19
03/19
16:43
03/19/19
16:43
Initiation
Altair initiated  »

Altair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.19

0.49 (2.16%)

16:42
03/19/19
03/19
16:42
03/19/19
16:42
Initiation
Mallinckrodt initiated  »

Mallinckrodt initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

LCI

Lannett

$8.05

0.17 (2.16%)

16:41
03/19/19
03/19
16:41
03/19/19
16:41
Initiation
Lannett initiated  »

Lannett initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
03/19/19
03/19
16:40
03/19/19
16:40
General news
API crude inventories for week of March 15 »

API reports that crude…

JAZZ

Jazz Pharmaceuticals

$135.47

1.02 (0.76%)

16:40
03/19/19
03/19
16:40
03/19/19
16:40
Initiation
Jazz Pharmaceuticals initiated  »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro suspends 2019 revenue guidance »

Nevro is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro CEO Rami Elghandour steps down, D. Keith Grossman to succeed »

Nevro announced that D.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

ENDP

Endo

$8.78

0.19 (2.21%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Endo initiated  »

Endo initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Hot Stocks
Ramaco Resources sees FY19 production of 2.0M tons of met coal »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

COST

Costco

$237.05

0.43 (0.18%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Costco initiated  »

Costco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 30

    May

TRN

Trinity Industries

$22.46

-0.25 (-1.10%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Conference/Events
Trinity Industries management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

COLL

Collegium Pharmaceutical

$17.35

-0.25 (-1.42%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Collegium Pharmaceutical initiated  »

Collegium Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.07

-0.35 (-2.13%)

16:37
03/19/19
03/19
16:37
03/19/19
16:37
Hot Stocks
Fulton Financial raises quarterly dividend 1c to 13c per share »

Fulton Financial said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:36
03/19/19
03/19
16:36
03/19/19
16:36
Earnings
Ramaco Resources reports Q4 EPS 8c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

BDSI

BioDelivery Sciences

$4.94

0.03 (0.61%)

16:35
03/19/19
03/19
16:35
03/19/19
16:35
Initiation
BioDelivery Sciences initiated  »

BioDelivery Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

AMAG

Amag Pharmaceuticals

$12.46

0.01 (0.08%)

16:34
03/19/19
03/19
16:34
03/19/19
16:34
Initiation
Amag Pharmaceuticals initiated  »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 23

    Mar

GCP

GCP Applied Technologies

$29.95

-0.475 (-1.56%)

16:34
03/19/19
03/19
16:34
03/19/19
16:34
Hot Stocks
GCP Applied Technologies names James Thompson VP, General Counsel and Secretary »

GCP Applied Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

KGJI

Kingold Jewelry

$0.89

0.0898 (11.22%)

16:33
03/19/19
03/19
16:33
03/19/19
16:33
Hot Stocks
Kingold Jewelry to file extension for Form 10-K »

Kingold Jewelry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$26.29

1.745 (7.11%)

16:33
03/19/19
03/19
16:33
03/19/19
16:33
Initiation
Bausch Health initiated  »

Bausch Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$18.65

-0.48 (-2.51%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Earnings
Tencent Music reports Q4 EPS 8c, consensus 8c »

Reports Q4 revenue $785M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

AMRX

Amneal Pharmaceuticals

$14.41

0.07 (0.49%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Initiation
Amneal Pharmaceuticals initiated  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

TTGT

TechTarget

$16.86

-0.07 (-0.41%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Hot Stocks
TechTarget CEO Cotoia sells over $134K in company shares »

TechTarget CEO Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 28

    May

FULT

Fulton Financial

$16.07

-0.35 (-2.13%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Hot Stocks
Fulton Financial authorizes up to $100M share repurchase »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.